Detail of the personalized-enhanced GCN. حسب Yuanming Ding (12842858)

الموضوعات:

Enhanced multi-component module. حسب Yuanming Ding (12842858)

الموضوعات:

The architecture of the TCBiL. حسب Yuanming Ding (12842858)

الموضوعات:

Detail of the encoder. حسب Yuanming Ding (12842858)

الموضوعات:

Detail of the Fourier transform. حسب Yuanming Ding (12842858)

الموضوعات:

Detail of the decoder. حسب Yuanming Ding (12842858)

الموضوعات:

Encoder-decoder architecture. حسب Yuanming Ding (12842858)

الموضوعات:

Dataset description. حسب Yuanming Ding (12842858)

الموضوعات:

PeMSD8. حسب Yuanming Ding (12842858)

الموضوعات:

Changes associated with kidney fibrosis in TGF- حسب Wencheng Jin (13136262)

The distribution of <i>Giardia duodenalis</i> assemblages in domestic and wild populations of nonhuman mammalian species with a larger number of isolates. حسب Kareem Hatam-Nahavandi (7384790)

الموضوعات:

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- حسب Wencheng Jin (13136262)

The characteristics and clinical features of 12 patients. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. حسب Masashi Okawa (8951294)

الموضوعات:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. حسب Masashi Okawa (8951294)

الموضوعات:

The original data for the figures. حسب Masashi Okawa (8951294)

الموضوعات:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)

الموضوعات:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات: